Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
J. Clin. Invest. Lemin Zheng, et al. 114:529 doi:10.1172/JCI21109 [Go to this article.]

Table 3
Relationship between serum total protein and apoA-I NO₂Tyr and ClTyr content and CVD prevalence